Abstract:Background: Glycemic variability (GV) is a novel parameter used in evaluating the quality of diabetes management. Current guidelines recommend the use of GV indexes alongside the traditional parameter to evaluate glycemic control: hemoglobin A1c (HbA1c). This study aims to evaluate the extent to which HbA1c explains the GV phenomena in patients with Type 1 diabetes (T1DM). Methods: In 147 patients with T1DM, associations between HbA1c and several GV indexes were analyzed. Results: Patients with an HbA1c < 7% had a lower median standard deviation of glycemia (60 vs. 48; p < 0.001), a lower coefficient of variation (34.1 vs. 38.0; p < 0.001), and a significantly increased median time in range (78 vs. 58; p < 0.001). HbA1c was positively correlated with the coefficient of variation (r = 0.349; p < 0.001) and the standard deviation (r = 0.656; p < 0.001) but reversely correlated with a lower time in range (r = −0.637; p < 0.001). Conclusions: HbA1c only partially explains the GV phenomena in patients with T1DM. The HbA1c value is associated more strongly with the time in range and standard deviation than with the coefficient of variation.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the relationship between glycated hemoglobin (HbA1c) and blood - glucose variability (GV) in patients with type 1 diabetes. Specifically, the study aims to evaluate to what extent HbA1c can explain the phenomenon of blood - glucose variability in patients with type 1 diabetes. By analyzing the associations between HbA1c and multiple blood - glucose variability indicators in 147 patients with type 1 diabetes, the study found that: - Patients with HbA1c values below 7% had lower blood - glucose standard deviation (SD), lower coefficient of variation (CV), and a significantly increased time in range (TIR) of blood - glucose. - HbA1c was positively correlated with CV and SD, but negatively correlated with TIR. - The conclusion points out that HbA1c only partially explains the phenomenon of blood - glucose variability in patients with type 1 diabetes. The correlations between HbA1c values and TIR and SD are stronger than that with CV. This study emphasizes the importance of using blood - glucose variability indicators in combination, in addition to HbA1c as a traditional parameter for evaluating blood - glucose control, for a more comprehensive understanding of blood - glucose management in patients with type 1 diabetes. This helps to identify those patients who may still be at a high risk of blood - glucose fluctuation even if their HbA1c levels meet the standards, thus providing more precise guidance for clinical treatment.

To What Extent Is HbA1c Associated with Glycemic Variability in Patients with Type 1 Diabetes? A Retrospective, Noninterventional Study